Lamotrigine oral liquid suspension and use thereof
OwnerPaul Sudhakar, Scott Boyerinventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to an oral liquid suspension that includes lamotrigine and methods of medical treatment that include administering the oral liquid suspension. The oral liquid suspension has desirable physicochemical properties and technical attributes. The oral liquid suspension is useful in patients having difficulties in swallowing tablets and provide medical practitioners with additional options for dose titration.
Claims25
A method for treating at least one of a neurological disorder and a mental disorder in a subject, the method comprising administering to a subject suffering from the disorder 0.1-25.0 mL of an oral liquid suspension consisting of:
- 3,5-diamino-6-(2,3-dichlorophenyl)-as-triazine (lamotrigine);
- water;
- glycerin;
- propylene glycol;
- polyethylene glycol;
- methylparaben;
- sodium benzoate;
- sorbitol;
- saccharin;
- sucralose;
- xanthan gum;
- carboxymethyl cellulose;
- sodium phosphate;
- microcrystalline cellulose and colloidal silicon dioxide;
- optionally, flavoring agent;
- and optionally, coloring agent.
Dependencies are inferred from the claim text.